10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2021 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 9, 2022) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 284,219 | 264,327 | 248,393 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (165,783) | (158,636) | (149,655) |
| Insurance benefits paid | (63,598) | (55,124) | (52,242) |
| Cash paid to other suppliers and employees | (31,652) | (29,763) | (28,932) |
| Interest and investment income received | 743 | 894 | 955 |
| Interest paid | (2,469) | (2,904) | (2,954) |
| Income taxes paid | (3,195) | (2,929) | (2,717) |
| Net cash provided by operating activities | 18,265 | 15,865 | 12,848 |
| Cash flows from investing activities: | |||
| Proceeds from sales and maturities of investments | 7,246 | 6,467 | 7,049 |
| Purchases of investments | (9,963) | (9,639) | (7,534) |
| Purchases of property and equipment | (2,520) | (2,437) | (2,457) |
| Proceeds from sale-leaseback transactions | 0 | 101 | 5 |
| Acquisitions (net of cash acquired) | (146) | (866) | (444) |
| Proceeds from sale of subsidiary | 0 | 840 | 0 |
| Other | 122 | 0 | 42 |
| Net cash used in investing activities | (5,261) | (5,534) | (3,339) |
| Cash flows from financing activities: | |||
| Net repayments of short-term debt | 0 | 0 | (720) |
| Proceeds from issuance of long-term debt | 987 | 9,958 | 3,736 |
| Repayments of long-term debt | (10,254) | (15,631) | (8,336) |
| Derivative settlements | 0 | (7) | (25) |
| Dividends paid | (2,625) | (2,624) | (2,603) |
| Proceeds from exercise of stock options | 549 | 264 | 210 |
| Payments for taxes related to net share settlement of equity awards | (168) | (88) | (112) |
| Other | 155 | 432 | 196 |
| Net cash used in financing activities | (11,356) | (7,696) | (7,654) |
| Net increase in cash, cash equivalents and restricted cash | 1,648 | 2,635 | 1,855 |
| Cash, cash equivalents and restricted cash at the beginning of the period | 11,043 | 8,408 | |
| Cash, cash equivalents and restricted cash at the end of the period | 12,691 | 11,043 | 8,408 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 7,898 | 7,192 | 6,631 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 4,512 | 4,441 | 4,371 |
| Store impairments | 1,358 | 0 | 231 |
| Goodwill impairment | 431 | 0 | 0 |
| Stock-based compensation | 484 | 400 | 453 |
| (Gain) loss on sale of subsidiaries | 0 | (269) | 205 |
| Loss on early extinguishment of debt | 452 | 1,440 | 79 |
| Deferred income taxes | (428) | (570) | (654) |
| Other noncash items | (390) | 72 | 33 |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (2,703) | (1,510) | (2,158) |
| Inventories | 735 | (973) | (1,075) |
| Other assets | (3) | 364 | (614) |
| Accounts payable and pharmacy claims and discounts payable | 2,898 | 2,769 | 3,550 |
| Health care costs payable and other insurance liabilities | 169 | (231) | 320 |
| Other liabilities | 2,852 | 2,740 | 1,476 |
| Net cash provided by operating activities | 18,265 | 15,865 | 12,848 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2021 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |